# Sourcing Quality Boswellia

For oncology-oriented use, generic Boswellia or frankincense products without meaningful **AKBA standardisation** are usually not enough.

### What to look for

1. a product that states **AKBA content** clearly
2. total boswellic acids are clearly stated
3. no unnecessary fillers
4. confidence about the extract quality and testing
5. practical ability to reach research-relevant daily intake

### Why AKBA matters

Many Boswellia products advertise only total boswellic acids, but the strongest oncology literature focuses specifically on **AKBA**.

That means a product can look strong on paper but still be weak for oncology-oriented use if it does not provide meaningful AKBA.

### Practical buying logic

When comparing Boswellia products, ask:

* How much AKBA does this provide?
* How much total extract is required to reach useful levels?
* Does the product make it practical to dose throughout the day?
* Is the extract likely to be better absorbed with food?

### Practical takeaway

For oncology-oriented discussion, AKBA-standardised Boswellia is more relevant than a generic frankincense or resin-support product.

### Group-trusted Boswellia options

At the moment, two MCS options are particularly relevant for readers seeking to align more closely with the AKBA-focused oncology literature.

#### Option 1 — Boswellia MEGA AKBA Liposomal

* **200 mg Boswellia serrata extract per capsule**
* **30% AKBA**
* **60 mg AKBA per capsule**
* **60 capsules**
* **€37.60**
* contains **piperlongumine**

This is the more accessible liposomal option and appears to be designed to improve absorption while still providing meaningful AKBA exposure.

Using the currently supplied product details:

* **4 capsules per day** would provide about **240 mg AKBA daily**
* That is a practical way to approximate the lower end of more treatment-oriented AKBA exposure

#### Option 2 — Inflasanum 200mg

* practitioner-script product
* described in group notes as a **higher-90% AKBA** Boswellia option
* described in the supplied notes as providing **180 mg AKBA per capsule**
* **60 capsules**
* **€82.72**
* does **not** contain piperlongumine

This is the more concentrated option and may be the better fit for readers who want:

* fewer capsules per day
* No piperlongumine in the formula
* a more clinician-supervised approach

> **Important note:** the product details supplied for Inflasanum include differing AKBA figures. Before using it for protocol-style dosing, readers should confirm the current label or product sheet directly so daily AKBA calculations are based on the exact active amount in the current version.

### What the difference means in practice

#### Boswellia MEGA AKBA Liposomal

Best for readers who want:

* a liposomal delivery format
* a lower-cost entry point
* a product that already includes a bioavailability-support strategy
* no script required

#### Inflasanum

Best for readers who want:

* a higher-strength, fewer-capsule approach
* a piperlongumine-free option
* a product more suited to supervised use, where the clinician is comfortable reviewing the full interaction picture

### Why the piperlongumine difference matters

Piperlongumine may improve the absorption of boswellic acids, which could be beneficial. But during active treatment, some readers may reasonably prefer a formula without it if there are concerns that extra absorption-enhancing effects could also alter concurrent drug and supplement tolerance or side-effect burden.

That does **not** mean piperlongumine is inappropriate. It means the choice between these two formulas may depend in part on how simple and conservative a patient wants the treatment-support stack to be during active therapy.

### Practical buying logic

The main questions are not just price or capsule count. They are:

1. How much **actual AKBA** does the product provide?
2. Is the formula designed to improve absorption?
3. Does it contain anything else, such as piperlongumine, that may change the clinical discussion?
4. Is the product realistic to dose at research-oriented levels without excessive capsule burden?

### Community discussions

Read about how other group members source and use high quality Boswellia with standardised high dose AKBA content. This image is located in the [study support group's ](/myhealingcommunity-docs/cancer-patient-community-supports/online-groups/facebook-groups/healing-cancer-study-support-facebook-group.md)media library and is the anchor to the constant conversation thread on this topic: [**Group discussion thread**](https://www.facebook.com/groups/healingcancerstudysupport/permalink/423380745244214/)

<figure><img src="/files/hI63IDL35hvzJ3RnZg8z" alt="Deep dive into Boswellia and AKBA in Oncology" width="488"><figcaption></figcaption></figure>

### Cancer Patient Community Most Trusted Products

**Boswellia MEGA AKBA Liposomal**\
<https://www.mcsformulas.com/vitamins-supplements/boswellia-akba-liposomal/ref/14>

**Inflasanum**\
<https://www.mcsformulas.com/vitamins-supplements/inflasanum-180mg/ref/14>

#### **Use the code `abbey5` at checkout to save 5%** **and help support the free Healing Cancer Study Support resources.**

### Important caution

This comparison is a practical interpretation of current product information, not a dosing prescription.

Formulation, food timing, absorption, treatment type, and drug interactions all matter. Boswellia still deserves the same interaction review as any active adjunct, especially in people using anticoagulants, corticosteroids, endocrine therapy, taxanes, or other CYP-relevant drugs.

### Jump to another Boswellia page

**Core pages**

* [Boswellia in Oncology Overview](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-in-oncology-overview.md)
* [Evidence Summary](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/evidence-summary.md)
* [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/anticancer-mechanisms.md)
* [Boswellia Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type.md)

**Mechanism deep dives**

* [Redox Dual Action](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/redox-dual-action.md)
* [NRF2 Impact](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/nrf2-impact.md)
* [Ferroptosis Findings](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/ferroptosis-findings.md)
* [Immune Effects](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/immune-effects.md)

**Practical pages**

* [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/pharmacokinetics-and-metabolism.md)
* [Safety & Interactions](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/safety-and-interactions.md)
* [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/synergistic-combinations.md)
* [Hydroxychloroquine + Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md)
* [Dosing & Timing](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/dosing-and-timing.md)
* [Sourcing Quality Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md)

**Cancer-type pages**

* [Glioblastoma & Brain Tumours](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md)
* [Breast Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/breast-cancer.md)
* [Colorectal Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/colorectal-cancer.md)
* [Pancreatic Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/pancreatic-cancer.md)
* [Prostate Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/prostate-cancer.md)
* [Non-Small Cell Lung Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/non-small-cell-lung-cancer.md)
* [Ovarian Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/ovarian-cancer.md)
* [Other Cancer Types](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/other-cancer-types.md)

{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}

{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
